Eiger BioPharmaceuticals, Inc. Annual Costs and Expenses in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2019 to 2023.
  • Eiger BioPharmaceuticals, Inc. Costs and Expenses for the quarter ending December 31, 2023 was $16.4M, a 39.6% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. Costs and Expenses for the twelve months ending December 31, 2023 was $87.6M, a 17.6% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Costs and Expenses for 2023 was $87.6M, a 17.6% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Costs and Expenses for 2022 was $106M, a 19.2% increase from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Costs and Expenses for 2021 was $89.1M, a 43.3% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $87.6M -$18.7M -17.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-08
2022 $106M +$17.1M +19.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-08
2021 $89.1M +$26.9M +43.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $62.1M -$6.76M -9.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-17
2019 $68.9M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.